Profile
SYRA HCA THC FMS UHS SOLV
Company Name Syra Health Corp. Class A Common Stock HCA Healthcare, Inc. Tenet Healthcare Corporation Fresenius Medical Care AG & Co. KGaA Universal Health Services, Inc. Solventum Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities
Market Cap $759.72K $104.60B $18.33B $15.75B $13.92B $11.74B
Employees 0.06K 226.00K 98.00K 112.04K 99.30K 22.00K
CEO Deepika Vuppalanchi Samuel N. Hazen Saumya Sutaria Helen Giza Marc D. Miller Bryan C. Hanson
Ratings
SYRA HCA THC FMS UHS SOLV
Quant Rating Score 2 2 4 3 3 3
Quant Rating Sell Sell Buy Neutral Neutral Neutral
Trading
SYRA HCA THC FMS UHS SOLV
Last Close $0.067 $471.36 $204.19 $24.3 $226.39 $66.28
High 52 $0.73 $473.2 $216.17 $29.85 $227.95 $84.04
Low 52 $0.05 $296.67 $110.41 $21.06 $154.99 $63.01
Price vs. 52 Week High -90.82 % -0.39 % -5.54 % -18.59 % -0.68 % -21.13 %
Price vs. 52 Week Low 34 % 58.88 % 84.94 % 15.38 % 46.07 % 5.19 %
Total Return
SYRA HCA THC FMS UHS SOLV
1 Month Return -33 % 7.73 % -0.32 % -9.4 % 7.96 % -8.16 %
3 Month Return -11.02 % 26.26 % 24.95 % 2.1 % 33.9 % -7.88 %
6 Month Return -33 % 30.58 % 34.05 % -13.95 % 21.29 % 1.21 %
9 Month Return -83.74 % 45.48 % 45.36 % -0.21 % 20.47 % -9.43 %
YTD Return -83.73 % 57.04 % 61.76 % 7.33 % 26.18 % 0.33 %
1 Year Return -83.67 % 32.39 % 21.17 % 13.92 % 8.63 % -11.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYRA HCA THC FMS UHS SOLV
Dividend Yield Percentage (TTM) - 0.63 % - 2.93 % 0.37 % -
Dividend Paid and Capex Coverage Ration (TTM) - 2.24 % 2.54 % 4.3 % 1.83 % 1.33 %
Dividend Per Share (TTM) - 2.82 % - 0.68 % 0.8 % -
Payout Ratio (TTM) - 46.97 % - - 5.67 % -
Profitability
SYRA HCA THC FMS UHS SOLV
Gross Profit Margin TTM 30.58 % 3.83 % 55.93 % 24.67 % 92.78 % 54.52 %
Return on Assets TTM -41.99 % 1.59 % 5.41 % 2.1 % 9 % 2.52 %
Return on Equity TTM -52.63 % -56.02 % 39.49 % 4.7 % 19.98 % 11.64 %
Return on Capital Employed TTM -60.77 % 3.7 % 13.98 % 5.77 % 16 % 6.24 %
Net Income Per EBT TTM 100 % 39.46 % 57.35 % 56.51 % 75.53 % 118.38 %
EBT Per Ebit TTM 99.37 % 129.84 % 79.8 % 78.59 % 93.83 % 41.31 %
EBIT Per Revenue TTM -18.19 % 3.83 % 16.67 % 7.57 % 11.47 % 9.26 %
Cash Flow To Debt Ratio TTM -498.05 % 150.16 % 2915.29 % 24.99 % 60.91 % 7.5 %
Receivables Turnover TTM 9.1 7.13 8.28 6.04 6.57 7.88
Payables Turnover TTM 10.05 17.06 6.78 19.56 - 5.93
Inventory Turnover TTM - 44.78 26.56 7.37 5.42 3.97
Fixed Asset Turnover TTM 21953.1 % 110.01 % 342.39 % 300.35 % 243.69 % 638.84 %
Asset Turnover TTM 232.3 % 81.11 % 70.89 % 62.38 % 110.74 % 55.65 %
Operating Cash Flow Per Share TTM -0.05 49.22 28.17 4.69 43.97 3.37
Free Cash Flow Per Share TTM -0.05 30.08 17.08 3.96 21.12 0.84
Cash Per Share TTM 19.31 % 411.2 % 3382.57 % 373.2 % 173.75 % 282.6 %
Operating Cash Flow Sales Ratio TTM -6.72 % 16.05 % 11.88 % 14.11 % 16.81 % 6.99 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 61.1 % 60.61 % 84.45 % 48.03 % 25.09 %
Cash Flow Coverage Ratios TTM -498.05 % 150.16 % 2915.29 % 24.99 % 60.91 % 7.5 %
Price To Free Cash Flows Ratio TTM -1.4 14.35 12.21 5.84 10.14 79.84
Price To Operating Cash Flows Ratio TTM -1.48 9.08 7.4 4.93 4.97 20.11
Price Cash Flow Ratio TTM -1.48 9.08 7.4 4.93 4.97 20.11
Income Statement (TTM)
SYRA HCA THC FMS UHS SOLV
Revenue $0.01B $70.6B $20.67B $19.34B $15.83B $8.25B
Gross Profit $0B $10.55B $8.21B $4.76B $14.24B $4.59B
Gross Profit Ratio 20.71% 14.94% 39.72% 24.6% 89.97% 55.65%
EBITDA $-0B $13.9B $6.89B $3.21B $2.27B $1.53B
Net Income $-0B $5.76B $3.2B $0.54B $1.14B $0.48B
EPS Diluted -0.52 22 32.7 0.92 16.82 2.76
Balance Sheet (MRQ)
SYRA HCA THC FMS UHS SOLV
Long Term Debt $0B $40.2B $14.03B $9.76B $4.84B $7.9B
Total Liabilities $0B $58.96B $20.39B $17.8B $7.71B $11.5B
Total Equity $0B $0.56B $8.55B $15.77B $6.76B $2.96B
Total Investments $0B $1.32B $1.81B $1.29B $0.32B $0.02B
Total Debt $0B $45.24B $14.33B $11B $4.96B $8.01B
Total Assets $0B $59.51B $28.94B $33.57B $14.47B $14.46B
Cash Flow Statement (TTM)
SYRA HCA THC FMS UHS SOLV
Net Income $-0B $6.66B $4.06B $0.74B $1.16B $0.48B
Inventory $0B $0.33B $-0.09B $0.11B $0B $-0.13B
Dividends Paid $0B $-0.69B $0B $-0.35B $-0.05B $0B
Operating Cash Flow $-0B $10.51B $2.05B $2.39B $2.07B $1.19B
Capital Expenditure $-0B $-4.88B $-0.93B $-0.7B $-0.94B $-0.38B
Related Stocks
Ticker Name Price
ACHC Acadia Healthcare Company, Inc. 20.26
ADUS Addus HomeCare Corporation 114.19
AGL agilon health, inc. 0.6972
AIH Aesthetic Medical International Holdings Group Limited 0.3334
AIRS AirSculpt Technologies, Inc. 10.49
ALR AlerisLife Inc. 1.32
AMED Amedisys, Inc. 100.99
AMEH Apollo Medical Holdings, Inc. 40.82
AMN AMN Healthcare Services, Inc. 18.43
AMS American Shared Hospital Services 2.11
AONC American Oncology Network, Inc. 9.89
ARDT Ardent Health Partners, LLC 14.46
ASTH Astrana Health, Inc. 33.36
ATIP ATI Physical Therapy, Inc. 0.675
AUNA 5.53
AVAH Aveanna Healthcare Holdings Inc. 8.63
BACK IMAC Holdings, Inc. 0.062
BKD Brookdale Senior Living Inc. 9.11
BKDT Brookdale Senior Living Inc. 7. 77.6
BTMD Haymaker Acquisition Corp. III 2.84
ETFs With Exposure to SYRA
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 329.37
VXF Vanguard Extended Market Index Fund 0 205.97
VTSAX Vanguard Total Stock Market Index Fund 0 160.27
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 156.17
VITSX Vanguard Total Stock Market Index Fund 0 160.3
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 156.18
VEMPX Vanguard Extended Market Index InstlPlus 0 385.39
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 300.71
Unlock